APA (7th ed.) Citation

AM, P., T, W., HL, C., CH, S., A, F., P, S., . . . CM, O. (2021). Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome. Radiation research, 195(2), 115. https://doi.org/10.1667/RADE-20-00181.1

Chicago Style (17th ed.) Citation

AM, Patterson, et al. "Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome." Radiation Research 195, no. 2 (2021): 115. https://doi.org/10.1667/RADE-20-00181.1.

MLA (9th ed.) Citation

AM, Patterson, et al. "Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome." Radiation Research, vol. 195, no. 2, 2021, p. 115, https://doi.org/10.1667/RADE-20-00181.1.